The Massachusetts Supreme Judicial Court ruled that Merck may be held liable for injuries caused by inadequate labeling for generics of its products. Source: Drug Industry Daily
President Trump said that his administration will cut nationwide opioid prescriptions by one third over the next three years and increase funding for non-addictive painkiller development. Source: Drug Industry Daily
The FDA served Terra Biological a warning letter for marketing a misbranded, unapproved new drug product on its website. Source: Drug Industry Daily
The FDA warned a French drug contract testing laboratory following a September inspection that revealed deficiencies in testing practices and discrepancy investigations. Source: Drug Industry Daily
Attorney General Jeff Sessions spoke in Lexington, Kentucky on Thursday, highlighting recently announced tools and programs geared towards fighting the U.S. opioid epidemic, including a team that will target online…
Doctors are five times more likely to prescribe a brand name drug if they receive payments from a pharmaceutical company for that drug, and the likelihood increases to 14.5 times…
The FDA requested comments on planned modifications to its MedWatch system that will impact existing forms used to report adverse events, including FDA 3500, 3500A and 3500B. Source: Drug Industry…
Representatives from the pharmaceutical and hospital industries agreed the 340B drug discount program needs reforms but disagreed as to what changes are needed in testimony before a Senate committee Thursday.…
A federal judge refused a motion by CIGNA to dismiss a class-action lawsuit alleging it artificially inflated the cost of prescription drugs. Source: Drug Industry Daily
Criminal and financial penalties against pharmaceutical manufacturers continued a downward trend in the past two years and financial penalties for unlawful promotion dropped dramatically since 2013, according to Public Citizen,…